Atovaquone Suspension
Product Images NDC 62135-528

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 62135-528). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

"image Description" (Atovaquone Oral Suspension Usp 210ml Bottle Label)

"image Description" (Atovaquone Oral Suspension Usp 210ml Bottle Label)
Atovaquone Oral Suspension, USP 750 mg/5 mL label for oral suspension by Chartwell Rx, LLC. The label indicates a 210 mL package size and includes storage instructions, barcode, and trademark information.*
FDA Label Image

"image Description" (Atovaquone Oral Suspension Usp Structure)

"image Description" (Atovaquone Oral Suspension Usp Structure)
Chemical structure of Atovaquone, showing its molecular components including a chlorophenyl group attached to a cyclohexane ring and a quinone moiety with hydroxyl and carbonyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.